6-(5-{5-[(E)-amino(hydroxyimino)methyl]pyridin-2-yl}-2-furyl)-N'-hydroxypyridine-3-carboximidamide

ID: ALA145118

Chembl Id: CHEMBL145118

PubChem CID: 136130326

Max Phase: Preclinical

Molecular Formula: C16H14N6O3

Molecular Weight: 338.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N/C(=N\O)c1ccc(-c2ccc(-c3ccc(/C(N)=N\O)cn3)o2)nc1

Standard InChI:  InChI=1S/C16H14N6O3/c17-15(21-23)9-1-3-11(19-7-9)13-5-6-14(25-13)12-4-2-10(8-20-12)16(18)22-24/h1-8,23-24H,(H2,17,21)(H2,18,22)

Standard InChI Key:  KNGZDDMFCPNENL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA145118

    ---

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma brucei rhodesiense (7991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyp1a2 Cytochrome P450 1A2 (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 338.33Molecular Weight (Monoisotopic): 338.1127AlogP: 1.59#Rotatable Bonds: 4
Polar Surface Area: 156.14Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.00CX Basic pKa: 13.62CX LogP: 0.42CX LogD: 0.42
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.24Np Likeness Score: -0.67

References

1. Ismail MA, Brun R, Easterbrook JD, Tanious FA, Wilson WD, Boykin DW..  (2003)  Synthesis and antiprotozoal activity of aza-analogues of furamidine.,  46  (22): [PMID:14561095] [10.1021/jm0302602]
2. Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, Brun R..  (2009)  New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.,  53  (10): [PMID:19620327] [10.1128/aac.00225-09]
3. Generaux CN, Ainslie GR, Bridges AS, Ismail MA, Boykin DW, Tidwell RR, Thakker DR, Paine MF..  (2013)  Compartmental and enzyme kinetic modeling to elucidate the biotransformation pathway of a centrally acting antitrypanosomal prodrug.,  41  (2): [PMID:23223498] [10.1124/dmd.112.048231]

Source